Skip to main content

March 2015, Vol 5, No 2

The Evolving Oncology Medical Home

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor, Practice Management

March 2015, Vol 5, No 2

New Model Is Announced for Oncology Care

March 2015, Vol 5, No 2

The World of Reimbursement Is Changing: Is Your Practice Ready?

By Jessica Turgon

March 2015, Vol 5, No 2

A New Care Model on the Horizon

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

March 2015, Vol 5, No 2

Personalized Medicine and Future Delivery Systems

By Gail Thompson

Personalized Medicine, Cancer Center Business Summit Highlights

March 2015, Vol 5, No 2

Cost-Effectiveness Analysis Shows Specialty Drugs Offer Value Despite High Cost

By Charles Bankhead

Practice Management

March 2015, Vol 5, No 2

Disability Insurance: Deciphering the COLA Rider

By Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF

Financial Management, Practice Management

March 2015, Vol 5, No 2

Trials Under Way for Patients with Brain Cancer

Clinical Trials Tracker

March 2015, Vol 5, No 2

Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non–Small-Cell Lung Cancer

By Loretta Fala

March 2015, Vol 5, No 2

Transforming Medicare Payments: Ambitious New Goals

March 2015, Vol 5, No 2

Page 1 of 2